1
|
Anetai Y, Takegawa H, Koike Y, Nakamura S, Tanigawa N. Effective optimization strategy for large optimization volume object, remaining volume at risk (RVR): α-value selection and usage from generalized equivalent uniform dose (gEUD) curve deviation perspective. Phys Med Biol 2023; 68. [PMID: 36745933 DOI: 10.1088/1361-6560/acb989] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Accepted: 02/06/2023] [Indexed: 02/08/2023]
Abstract
Objective.A large optimization volume for intensity-modulated radiation therapy (IMRT), such as the remaining volume at risk (RVR), is traditionally unsuitable for dose-volume constraint control and requires planner-specific empirical considerations owing to the patient-specific shape. To enable less empirical optimization, the generalized equivalent uniform dose (gEUD) optimization is effective; however, the utilization of parametera-values remains elusive. Our study clarifies thea-value characteristics for optimization and to enable effectivea-value use.Approach.The gEUD can be obtained as a function of itsa-value, which is the weighted generalized mean; its curve has a continuous, differentiable, and sigmoid shape, deforming in its optimization state with retained curve characteristics. Using differential geometry, the gEUD curve changes in optimization is considered a geodesic deviation intervened by the forces between deforming and retaining the curve. The curvature and gradient of the curve are radically related to optimization. The vertex point (a=ak) was set and thea-value roles were classified into the following three parts of the curve with respect to thea-value: (i) high gradient and middle curvature, (ii) middle gradient and high curvature, and (iii) low gradient and low curvature. Then, a strategy for multiplea-values was then identified using RVR optimization.Main results.Eleven head and neck patients who underwent static seven-field IMRT were used to verify thea-value characteristics and curvature effect for optimization. The lowera-value (i) (a= 1-3) optimization was effective for the whole dose-volume range; in contrast, the effect of highera-value (iii) (a= 12-20) optimization addressed strongly the high-dose range of the dose volume. The middlea-value (ii) (arounda=ak) showed intermediate but effective high-to-low dose reduction. Thesea-value characteristics were observed as superimpositions in the optimization. Thus, multiple gEUD-based optimization was significantly superior to the exponential constraints normally applied to the RVR that surrounds the PTV, normal tissue objective (NTO), resulting in up to 25.9% and 8.1% improvement in dose-volume indices D2% and V10Gy, respectively.Significance.This study revealed an appropriatea-value for gEUD optimization, leading to favorable dose-volume optimization for the RVR region using fixed multiplea-value conditions, despite the very large and patient-specific shape of the region.
Collapse
Affiliation(s)
- Yusuke Anetai
- Department of Radiology, Kansai Medical University, Shin-machi 2-5-1, Hirakata-shi, Osaka 573-1010, Japan
| | - Hideki Takegawa
- Department of Radiology, Kansai Medical University, Shin-machi 2-5-1, Hirakata-shi, Osaka 573-1010, Japan
| | - Yuhei Koike
- Department of Radiology, Kansai Medical University, Shin-machi 2-5-1, Hirakata-shi, Osaka 573-1010, Japan
| | - Satoaki Nakamura
- Department of Radiology, Kansai Medical University, Shin-machi 2-5-1, Hirakata-shi, Osaka 573-1010, Japan
| | - Noboru Tanigawa
- Department of Radiology, Kansai Medical University, Shin-machi 2-5-1, Hirakata-shi, Osaka 573-1010, Japan
| |
Collapse
|
2
|
Insley B, Hsu IC, Cunha JAM. Paradigm Shift in Radiation Treatment Planning Over Multiple Treatment Modalities. J Med Phys 2021; 46:135-139. [PMID: 34703096 PMCID: PMC8491309 DOI: 10.4103/jmp.jmp_66_20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2020] [Revised: 07/07/2021] [Accepted: 07/08/2021] [Indexed: 11/20/2022] Open
Abstract
The inverse planning simulated annealing optimization engine was used to develop a new method of incorporating biological parameters into radiation treatment planning. This method integrates optimization of a radiation schedule over multiple types of delivery methods into a single algorithm. We demonstrate a general procedure of incorporating a functional biological dose model into the calculation of physical dose prescriptions. This paradigm differs from current practice in that it combines biology-informed dose constraints with a physical dose optimizer allowing for the comparison of treatment plans across multiple different radiation types and fractionation schemes.
Collapse
Affiliation(s)
- Benjamin Insley
- Department of Physics, Brown University, Providence, Rhode Island, USA
| | - I-Chow Hsu
- Department of Radiation Oncology, University of California, San Francisco, California, USA
| | - J Adam Martin Cunha
- Department of Radiation Oncology, University of California, San Francisco, California, USA
| |
Collapse
|
3
|
Duan Y, Cao H, Wu B, Wu Y, Liu D, Zhou L, Feng A, Wang H, Chen H, Gu H, Shao Y, Huang Y, Lin Y, Ma K, Fu X, Fu H, Kong Q, Xu Z. Dosimetric Comparison, Treatment Efficiency Estimation, and Biological Evaluation of Popular Stereotactic Radiosurgery Options in Treating Single Small Brain Metastasis. Front Oncol 2021; 11:716152. [PMID: 34540686 PMCID: PMC8447903 DOI: 10.3389/fonc.2021.716152] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2021] [Accepted: 07/14/2021] [Indexed: 11/24/2022] Open
Abstract
Objectives This study aimed to show the advantages of each stereotactic radiosurgery (SRS) treatment option for single small brain metastasis among Gamma Knife (GK), Cone-based VMAT (Cone-VMAT), and MLC-based CRT (MLC-CRT) plans. Materials and Methods GK, Cone-VMAT, and MLC-CRT SRS plans were retrospectively generated for 11 patients with single small brain metastasis whose volume of gross tumor volume (GTV) ranged from 0.18 to 0.76 cc (median volume 0.60 cc). Dosimetric parameters, treatment efficiency, and biological parameters of the three techniques were compared and evaluated. The metric variation with the planning target volume (PTV) was also studied. Results The conformity index (CI) was similar in GK and MLC-CRT plans, higher than Cone-VMAT. Cone-VMAT achieved comparable volume covered by 12 Gy (V12) and gradient index (GI) as GK, lower than MLC-CRT. The heterogeneity index (HI) of GK, Cone-VMAT, and MLC-CRT decreased sequentially. GK gave the lowest volume covered by 3 Gy (V3) and 6 Gy (V6), while MLC-CRT got the highest. The beam-on time and treatment time of GK, Cone-VMAT, and MLC-CRT decreased in turn. Tumor control probability (TCP) of all three SRS plans was greater than 98%, and normal tissue complication probability (NTCP) of all organs at risk (OARs) was below 0.01%. GK and Cone-VMAT resulted in superior TCP and NTCP of the normal brain tissue than MLC-CRT. The relative value of Cone-VMAT and GK for all metrics hardly changed with the target volume. Except for the unchanged HI and TCP, the other results of MLC-CRT with respect to GK improved as the target volume increased. MLC-CRT could produce higher CI than GK and Cone-VMAT when the target volume increased above 2 and 1.44 cc, respectively. Conclusion For single small brain metastases, Cone-VMAT may be used as an alternative to GK-free centers. In addition to the advantage of short treatment time, MLC-CRT showed superiority in CI as the target volume increased. Treatment centers can choose appropriate SRS technique on a case-by-case basis according to institutional conditions and patients’ individual needs.
Collapse
Affiliation(s)
- Yanhua Duan
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Hongbin Cao
- Department of Radiation Oncology, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Boheng Wu
- Department of Radiation Oncology, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Yinghui Wu
- Nuclear Protective Treatment Department of Radiation, Navy Specialty Medical Center, Shanghai, China
| | - Dong Liu
- Varian Medical Systems, Inc., Beijing, China
| | - Lijun Zhou
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
| | - Aihui Feng
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Hao Wang
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Hua Chen
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Hengle Gu
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Yan Shao
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Ying Huang
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Yang Lin
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Kui Ma
- Varian Medical Systems, Inc., Beijing, China
| | - Xiaolong Fu
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Hong Fu
- Department of Mathematics and Information Technology, The Education University of Hong Kong, Hong Kong, China
| | - Qing Kong
- Institute of Modern Physics, Fudan University, Shanghai, China
| | - Zhiyong Xu
- Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| |
Collapse
|
4
|
The status of medical physics in radiotherapy in China. Phys Med 2021; 85:147-157. [PMID: 34010803 DOI: 10.1016/j.ejmp.2021.05.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 05/01/2021] [Accepted: 05/03/2021] [Indexed: 01/09/2023] Open
Abstract
PURPOSE To present an overview of the status of medical physics in radiotherapy in China, including facilities and devices, occupation, education, research, etc. MATERIALS AND METHODS: The information about medical physics in clinics was obtained from the 9-th nationwide survey conducted by the China Society for Radiation Oncology in 2019. The data of medical physics in education and research was collected from the publications of the official and professional organizations. RESULTS By 2019, there were 1463 hospitals or institutes registered to practice radiotherapy and the number of accelerators per million population was 1.5. There were 4172 medical physicists working in clinics of radiation oncology. The ratio between the numbers of radiation oncologists and medical physicists is 3.51. Approximately, 95% of medical physicists have an undergraduate or graduate degrees in nuclear physics and biomedical engineering. 86% of medical physicists have certificates issued by the Chinese Society of Medical Physics. There has been a fast growth of publications by authors from mainland of China in the top international medical physics and radiotherapy journals since 2018. CONCLUSIONS Demand for medical physicists in radiotherapy increased quickly in the past decade. The distribution of radiotherapy facilities in China became more balanced. High quality continuing education and training programs for medical physicists are deficient in most areas. The role of medical physicists in the clinic has not been clearly defined and their contributions have not been fully recognized by the community.
Collapse
|
5
|
Split Common Coincidence Point Problem: A Formulation Applicable to (Bio)Physically-Based Inverse Planning Optimization. Symmetry (Basel) 2020. [DOI: 10.3390/sym12122086] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Inverse planning is a method of radiotherapy treatment planning where the care team begins with the desired dose distribution satisfying prescribed clinical objectives, and then determines the treatment parameters that will achieve it. The variety in symmetry, form, and characteristics of the objective functions describing clinical criteria requires a flexible optimization approach in order to obtain optimized treatment plans. Therefore, we introduce and discuss a nonlinear optimization formulation called the split common coincidence point problem (SCCPP). We show that the SCCPP is a suitable formulation for the inverse planning optimization problem with the flexibility of accommodating several biological and/or physical clinical objectives. Also, we propose an iterative algorithm for approximating the solution of the SCCPP, and using Bregman techniques, we establish that the proposed algorithm converges to a solution of the SCCPP and to an extremum of the inverse planning optimization problem. We end with a note on useful insights on implementing the algorithm in a clinical setting.
Collapse
|
6
|
Meier V, Besserer J, Rohrer Bley C. Using biologically based objectives to optimize boost intensity-modulated radiation therapy planning for brainstem tumors in dogs. Vet Radiol Ultrasound 2019; 61:77-84. [PMID: 31600027 PMCID: PMC7004177 DOI: 10.1111/vru.12815] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2019] [Revised: 06/22/2019] [Accepted: 09/07/2019] [Indexed: 12/17/2022] Open
Abstract
Irradiated brain tumors commonly progress at the primary site, generating interest in focal dose escalation. The aim of this retrospective observational study was to use biological optimization objectives for a modeling exercise with simultaneously‐integrated boost IMRT (SIB‐IMRT) to generate a dose‐escalated protocol with acceptable late radiation toxicity risk estimate and improve tumor control for brainstem tumors in dogs safely. We re‐planned 20 dog brainstem tumor datasets with SIB‐IMRT, prescribing 20 × 2.81 Gy to the gross tumor volume (GTV) and 20 × 2.5 Gy to the planning target volume. During the optimization process, we used biologically equivalent generalized equivalent uniform doses (gEUD) as planning aids. These were derived from human data, calculated to adhere to normal tissue complication probability (NTCP) ≤5%, and converted to the herein used fractionation schedule. We extracted the absolute organ at risk dose‐volume histograms to calculate NTCP of each individual plan. For planning optimization, gEUD(a = 4) = 39.8 Gy for brain and gEUD(a = 6.3) = 43.8 Gy for brainstem were applied. Mean brain NTCP was low with 0.43% (SD ±0.49%, range 0.01‐2.04%); mean brainstem NTCP was higher with 7.18% (SD ±4.29%, range 2.87‐20.72%). Nevertheless, NTCP of < 10% in brainstem was achievable in 80% (16/20) of dogs. Spearman's correlation between relative GTV and NTCP was high (ρ = 0.798, P < .001), emphasizing increased risk with relative size even with subvolume‐boost. Including biologically based gEUD values into optimization allowed estimating NTCP during the planning process. In conclusion, gEUD‐based SIB‐IMRT planning resulted in dose‐escalated treatment plans with acceptable risk estimate of NTCP < 10% in the majority of dogs with brainstem tumors. Risk was correlated with relative tumor size.
Collapse
Affiliation(s)
- Valeria Meier
- Division of Radiation Oncology, Small Animal Department, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.,Department of Physics, University of Zurich, Zurich, Switzerland
| | - Jürgen Besserer
- Division of Radiation Oncology, Small Animal Department, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.,Department of Physics, University of Zurich, Zurich, Switzerland.,Radiation Oncology, Hirslanden Clinic, Zurich, Switzerland
| | - Carla Rohrer Bley
- Division of Radiation Oncology, Small Animal Department, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
| |
Collapse
|
7
|
Lin TA, Lin JS, Wagner T, Pham N. Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions. J Gastrointest Oncol 2018; 9:858-870. [PMID: 30505586 DOI: 10.21037/jgo.2018.06.01] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
Stereotactic body radiation therapy (SBRT) is a form of radiation therapy that has been used in the treatment of primary hepatocellular carcinoma (HCC) over the past decade. To evaluate the clinical efficacy of SBRT in primary HCC, a literature search was conducted to identify original research articles published from January 2000 through January 2018 in PubMed on SBRT in HCC. All relevant studies published from 2004 to 2018 were included. Prospective studies demonstrated 2-year local control (LC) rates ranging from 64-95% and overall survival (OS) rates ranging from 34% (2-year) to 65% (3-year). Retrospective studies demonstrated 2-year LC rates of 44-90% and 2-year OS rates of 24-67%. Reported toxicities in primary HCC patients vary but SBRT appears to be relatively well tolerated. Studies comparing SBRT to radiofrequency ablation (RFA) are few, but they suggest SBRT may be more effective than RFA in specific primary HCC populations. Additionally, SBRT appears to increase the efficacy of both transarterial chemoembolization (TACE) and sorafenib in selected primary HCC populations.
Collapse
Affiliation(s)
- Timothy A Lin
- Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA
| | - Jessica S Lin
- Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA
| | - Timothy Wagner
- Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA
| | - Ngoc Pham
- Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA
| |
Collapse
|
8
|
Fogliata A, Thompson S, Stravato A, Tomatis S, Scorsetti M, Cozzi L. On the gEUD biological optimization objective for organs at risk in Photon Optimizer of Eclipse treatment planning system. J Appl Clin Med Phys 2017; 19:106-114. [PMID: 29152846 PMCID: PMC5768006 DOI: 10.1002/acm2.12224] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2017] [Revised: 10/13/2017] [Accepted: 10/16/2017] [Indexed: 11/12/2022] Open
Abstract
Inverse planning optimization using biologically based objectives is becoming part of the intensity modulated optimization process. The performances and efficacy of the biologically based gEUD (generalized Equivalent Uniform Dose) objective implemented in the Photon Optimizer (PO) of Varian Eclipse treatment planning system have been here analyzed. gEUD is associated with the parameter a that accounts for the seriality of a structure, being higher for more serial organs. The PO was used to optimize volumetric modulated arc therapy (VMAT) plans on a virtual homogeneous cylindrical phantom presenting a target and an organ at risk (OAR). The OAR was placed at 4 mm, 1 and 2 cm distance, or cropped at 0, 2 and 4 mm from the target. Homogeneous target dose of 60 Gy in 20 fractions was requested with physical dose-volume objectives, while OAR dose was minimized with the upper gEUD objective. The gEUD specific a parameter was varied from 0.1 to 40 to assess its impact to OAR sparing and target coverage. Actual head and neck and prostate cases, with one parotid and the rectum as test OAR, were also analyzed to translate the results in the more complex clinical environment. Increasing the a parameter value in the gEUD objective, the optimization achieved lower volumes of the OAR which received the highest dose levels. The maximum dose in the OAR was minimized well with a values up to 20, while further increase of a to 40 did not further improve the result. The OAR mean dose was reduced for the OAR located at 1 and 2 cm distance from the target, enforced with increasing a. For cropped OARs, a mean dose reduction was achieved for a values up to 3-5, but mean dose increased for higher a values. The optimal choice of the parameter a depends on the mutual OAR and target position, and seriality of the organ. Today no significant compendium of clinical and biological specific a and gEUD values are available for a wide range of OARs.
Collapse
Affiliation(s)
- Antonella Fogliata
- Radiotherapy and Radiosurgery Department, Humanitas Research Hospital and Cancer Center, Milan, Rozzano, Italy
| | | | - Antonella Stravato
- Radiotherapy and Radiosurgery Department, Humanitas Research Hospital and Cancer Center, Milan, Rozzano, Italy
| | - Stefano Tomatis
- Radiotherapy and Radiosurgery Department, Humanitas Research Hospital and Cancer Center, Milan, Rozzano, Italy
| | - Marta Scorsetti
- Radiotherapy and Radiosurgery Department, Humanitas Research Hospital and Cancer Center, Milan, Rozzano, Italy.,Biomedicine Faculty, Humanitas University, Milan, Rozzano, Italy
| | - Luca Cozzi
- Radiotherapy and Radiosurgery Department, Humanitas Research Hospital and Cancer Center, Milan, Rozzano, Italy.,Biomedicine Faculty, Humanitas University, Milan, Rozzano, Italy
| |
Collapse
|